FREE COMMUNICATION 20

17.00-18.30   G106-G107

 

Dialysis mineral bone disease
 

Chairs: Jürgen Floege, Aachen, Germany
             Joao M. Frazao, Porto, Portugal
 
Mini lecture
FGF23: a cardiovascular risk factor in the making?
Danilo Fliser, Homburg/Saar, Germany
 
FREE COMMUNICATIONS
 

MO043
ADDITION OF SEVELAMER HYDROCHLORIDE ASSOCIATES WITH IMPROVED SURVIVAL ON
HEMODIALYSIS: THE JAPAN DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (J-DOPPS)
Hirotaka Komaba1,2, Masatomo Taniguchi3,4, Suguru Yamamoto5, Takanobu Nomura6, Masafumi
Fukagawa1 1Tokai Univ School of Medicine, Isehara, Japan, 2Harvard School of Dental Medicine, Boston, MA; 3Graduate School of Medical Sciences, Kyushu Univ, Fukuoka, Japan, 4Univ Texas Southwestern Medical Center, Dallas, TX; 5Niigata Univ Graduate School of Medical and Dental Science, Niigata, Japan, 6Kyowa Hakko Kirin Co. Ltd, Tokyo, Japan
 
MO044
SERUM CALCIFICATION PROPENSITY OF HD PATIENTS IS THERAPEUTICALLY IMPROVED BY A
CALCIUM ACETATE/MAGNESIUM CARBONATE CONTAINING PHOSPHATE BINDER
Andreas Pasch1, Angel LM De Francisco2, Adrian Covic3, Barbara Marzell4, Hans J Arens4, Jutta
Passlick-Deetjen5, Wilhelm Jahnen-Dechent6,7
1Inselspital, Bern, Switzerland, 2Univ Cantabria, Santander, Spain, 3C. I. Parhon Univ Hosp, Gr T. Popa, Iasi, Romania, 4Fresenius Medical Care, Bad Homburg, Germany, 5Heinrich-Heine Univ, Düsseldorf, Germany, 6RWTH Aachen Univ, Aachen, Germany, 7Helmholtz-Inst Biomedical Engineering, Aachen, Germany
 
MO045
CALCIUM MASS BALANCE IN HIGH EFFICIENCY ON-LINE CONVECTIVE THERAPIES WITH DIFFERENT
INFUSION MODALITIES .
Angelo Castellano1, Pio Ruggiero2, Luciano Alberto Pedrini3 1Nephrocare, Seriate, Italy, 2Nephrology and Dialysis - Bolognini Hosp, Seriate, Italy, 3Nephrology and Dialysis Nephrocare - Bolognini Hosp, Seriate, Italy
 
MO046
VARIABILITY IN MINERAL METABOLISM PARAMETERS IS ASSOCIATED WITH AN INCREASED
RISK FOR HOSPIZATIONS: RESULTS FROM THE MONDO CONSORTIUM
Fellype Barreto1, Aileen Grassmann2, Daniele Marcelli2, Bernard Canaud2, Peter Kotanko3, Viviane C. Silva1, Len Usvyat4,3, Roberto Pecoits-Filho1, Mondo Consortium3 1Pontifícia Univ Católica do Paraná, Curitiba, Brazil, 2Fresenius Medical Care, Bad Homburg, Germany, 3Renal Research Inst, New York, NY; 4Fresenius Medical Care North America, Waltham, MA
 
MO047
EFFECTS OF CINACALCET ON FRACTURE EVENTS IN PATIENTS RECEIVING HEMODIALYSIS:
THE EVOLVE TRIAL
Tilman B Drueke1, Sharon M Moe2, Safa Abdalla3, Patrick S. Parfrey4, Glenn M Chertow5
1INSERM Unit 1088, Amiens, France, 2Indiana Univ School of Medicine, Indianapolis, IN; 3Stanford
Univ, Palo Alto, CA; 4Health Sciences Center, St. John’s, NL, Canada, 5Stanford Univ School of Medicine, Palo Alto, CA 
  

back to the timetable